- Home
- SGC vs TSVT Comparison
SGC vs TSVT Comparison
Compare SGC & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- TSVT
- Stock Information
- Founded
- SGC 1920
- TSVT 2021
- Country
- SGC United States
- TSVT United States
- Employees
- SGC N/A
- TSVT N/A
- Industry
- SGC Apparel
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- SGC Consumer Discretionary
- TSVT Health Care
- Exchange
- SGC Nasdaq
- TSVT Nasdaq
- Market Cap
- SGC 252.6M
- TSVT 253.9M
- IPO Year
- SGC N/A
- TSVT N/A
- Fundamental
- Price
- SGC $15.05
- TSVT $4.88
- Analyst Decision
- SGC Strong Buy
- TSVT Buy
- Analyst Count
- SGC 2
- TSVT 6
- Target Price
- SGC $22.00
- TSVT $10.40
- AVG Volume (30 Days)
- SGC 79.3K
- TSVT 347.3K
- Earning Date
- SGC 11-04-2024
- TSVT 11-12-2024
- Dividend Yield
- SGC 3.70%
- TSVT N/A
- EPS Growth
- SGC N/A
- TSVT N/A
- EPS
- SGC 0.68
- TSVT N/A
- Revenue
- SGC $553,945,000.00
- TSVT $44,120,000.00
- Revenue This Year
- SGC $4.89
- TSVT N/A
- Revenue Next Year
- SGC $4.84
- TSVT $22.42
- P/E Ratio
- SGC $22.31
- TSVT N/A
- Revenue Growth
- SGC 1.22
- TSVT N/A
- 52 Week Low
- SGC $7.40
- TSVT $1.54
- 52 Week High
- SGC $21.80
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- SGC 50.20
- TSVT 54.82
- Support Level
- SGC $14.95
- TSVT $4.60
- Resistance Level
- SGC $15.28
- TSVT $4.92
- Average True Range (ATR)
- SGC 0.34
- TSVT 0.34
- MACD
- SGC 0.01
- TSVT 0.00
- Stochastic Oscillator
- SGC 40.00
- TSVT 65.69
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.